nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—bronchus—chronic obstructive pulmonary disease	0.00877	0.284	CbGeAlD
Sodium stibogluconate—TOP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00858	0.278	CbGeAlD
Sodium stibogluconate—TOP1—trachea—chronic obstructive pulmonary disease	0.00788	0.255	CbGeAlD
Sodium stibogluconate—TOP1—lung—chronic obstructive pulmonary disease	0.00566	0.183	CbGeAlD
Sodium stibogluconate—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00371	0.00383	CcSEcCtD
Sodium stibogluconate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00369	0.00381	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00366	0.00378	CcSEcCtD
Sodium stibogluconate—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00363	0.00375	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00362	0.00374	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00358	0.00369	CcSEcCtD
Sodium stibogluconate—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00355	0.00366	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00353	0.00365	CcSEcCtD
Sodium stibogluconate—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.00361	CcSEcCtD
Sodium stibogluconate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00343	0.00354	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00352	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00341	0.00352	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00339	0.0035	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00339	0.0035	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00348	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00348	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00318	0.00328	CcSEcCtD
Sodium stibogluconate—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00316	0.00326	CcSEcCtD
Sodium stibogluconate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00314	0.00324	CcSEcCtD
Sodium stibogluconate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00312	0.00322	CcSEcCtD
Sodium stibogluconate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0031	0.0032	CcSEcCtD
Sodium stibogluconate—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.00308	0.00318	CcSEcCtD
Sodium stibogluconate—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00306	0.00316	CcSEcCtD
Sodium stibogluconate—Abscess—Prednisone—chronic obstructive pulmonary disease	0.00306	0.00315	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00301	0.0031	CcSEcCtD
Sodium stibogluconate—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00309	CcSEcCtD
Sodium stibogluconate—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00299	0.00308	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00296	0.00305	CcSEcCtD
Sodium stibogluconate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00294	0.00304	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00293	0.00302	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.00299	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.00297	CcSEcCtD
Sodium stibogluconate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00295	CcSEcCtD
Sodium stibogluconate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00286	0.00295	CcSEcCtD
Sodium stibogluconate—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00283	0.00292	CcSEcCtD
Sodium stibogluconate—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00292	CcSEcCtD
Sodium stibogluconate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00281	0.0029	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00276	0.00284	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.00284	CcSEcCtD
Sodium stibogluconate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00275	0.00283	CcSEcCtD
Sodium stibogluconate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00275	0.00283	CcSEcCtD
Sodium stibogluconate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00272	0.00281	CcSEcCtD
Sodium stibogluconate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00272	0.00281	CcSEcCtD
Sodium stibogluconate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.0028	CcSEcCtD
Sodium stibogluconate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00271	0.00279	CcSEcCtD
Sodium stibogluconate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00278	CcSEcCtD
Sodium stibogluconate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00269	0.00278	CcSEcCtD
Sodium stibogluconate—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00267	0.00276	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.00275	CcSEcCtD
Sodium stibogluconate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00265	0.00274	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00271	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00271	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00269	CcSEcCtD
Sodium stibogluconate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00257	0.00265	CcSEcCtD
Sodium stibogluconate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00256	0.00264	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00258	CcSEcCtD
Sodium stibogluconate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00258	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.00256	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00244	0.00252	CcSEcCtD
Sodium stibogluconate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00245	CcSEcCtD
Sodium stibogluconate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00245	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00236	0.00243	CcSEcCtD
Sodium stibogluconate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00233	0.0024	CcSEcCtD
Sodium stibogluconate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00232	0.0024	CcSEcCtD
Sodium stibogluconate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.0023	0.00237	CcSEcCtD
Sodium stibogluconate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00229	0.00236	CcSEcCtD
Sodium stibogluconate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00236	CcSEcCtD
Sodium stibogluconate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00236	CcSEcCtD
Sodium stibogluconate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00228	0.00235	CcSEcCtD
Sodium stibogluconate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00235	CcSEcCtD
Sodium stibogluconate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00235	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.00235	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.00235	CcSEcCtD
Sodium stibogluconate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00235	CcSEcCtD
Sodium stibogluconate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00231	CcSEcCtD
Sodium stibogluconate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00223	0.0023	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.0023	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00222	0.00229	CcSEcCtD
Sodium stibogluconate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00226	CcSEcCtD
Sodium stibogluconate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00226	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00226	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00226	CcSEcCtD
Sodium stibogluconate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00225	CcSEcCtD
Sodium stibogluconate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00225	CcSEcCtD
Sodium stibogluconate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00223	CcSEcCtD
Sodium stibogluconate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00216	0.00223	CcSEcCtD
Sodium stibogluconate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00222	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00222	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00222	CcSEcCtD
Sodium stibogluconate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00222	CcSEcCtD
Sodium stibogluconate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00221	CcSEcCtD
Sodium stibogluconate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00221	CcSEcCtD
Sodium stibogluconate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00213	0.0022	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.00219	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.00217	CcSEcCtD
Sodium stibogluconate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.0021	0.00217	CcSEcCtD
Sodium stibogluconate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00214	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00214	CcSEcCtD
Sodium stibogluconate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00212	CcSEcCtD
Sodium stibogluconate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00211	CcSEcCtD
Sodium stibogluconate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00211	CcSEcCtD
Sodium stibogluconate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Sodium stibogluconate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.0021	CcSEcCtD
Sodium stibogluconate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00203	0.0021	CcSEcCtD
Sodium stibogluconate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00208	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Sodium stibogluconate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00204	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00197	0.00203	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.00202	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00195	0.00202	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00194	0.002	CcSEcCtD
Sodium stibogluconate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.002	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00199	CcSEcCtD
Sodium stibogluconate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00198	CcSEcCtD
Sodium stibogluconate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.00197	CcSEcCtD
Sodium stibogluconate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00195	CcSEcCtD
Sodium stibogluconate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00195	CcSEcCtD
Sodium stibogluconate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00193	CcSEcCtD
Sodium stibogluconate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00193	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00192	CcSEcCtD
Sodium stibogluconate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00191	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0019	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00189	CcSEcCtD
Sodium stibogluconate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00183	0.00189	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00182	0.00188	CcSEcCtD
Sodium stibogluconate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00187	CcSEcCtD
Sodium stibogluconate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00187	CcSEcCtD
Sodium stibogluconate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Sodium stibogluconate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00185	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00185	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00185	CcSEcCtD
Sodium stibogluconate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00184	CcSEcCtD
Sodium stibogluconate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00183	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00181	CcSEcCtD
Sodium stibogluconate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00174	0.0018	CcSEcCtD
Sodium stibogluconate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.0018	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00179	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00179	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00179	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00179	CcSEcCtD
Sodium stibogluconate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00178	CcSEcCtD
Sodium stibogluconate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00177	CcSEcCtD
Sodium stibogluconate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00177	CcSEcCtD
Sodium stibogluconate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.00177	CcSEcCtD
Sodium stibogluconate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00176	CcSEcCtD
Sodium stibogluconate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00176	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00175	CcSEcCtD
Sodium stibogluconate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00173	CcSEcCtD
Sodium stibogluconate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.0017	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00167	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00167	CcSEcCtD
Sodium stibogluconate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00167	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00163	CcSEcCtD
Sodium stibogluconate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Sodium stibogluconate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Sodium stibogluconate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.0016	CcSEcCtD
Sodium stibogluconate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00155	0.0016	CcSEcCtD
Sodium stibogluconate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00159	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00158	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00157	CcSEcCtD
Sodium stibogluconate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00157	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00155	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00155	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00154	CcSEcCtD
Sodium stibogluconate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00153	CcSEcCtD
Sodium stibogluconate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00153	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00152	CcSEcCtD
Sodium stibogluconate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Sodium stibogluconate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Sodium stibogluconate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Sodium stibogluconate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00147	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Sodium stibogluconate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00144	CcSEcCtD
Sodium stibogluconate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00144	CcSEcCtD
Sodium stibogluconate—Rash—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Sodium stibogluconate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Sodium stibogluconate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Sodium stibogluconate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Sodium stibogluconate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00142	CcSEcCtD
Sodium stibogluconate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00142	CcSEcCtD
Sodium stibogluconate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Sodium stibogluconate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Sodium stibogluconate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Sodium stibogluconate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00135	0.0014	CcSEcCtD
Sodium stibogluconate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00135	0.0014	CcSEcCtD
Sodium stibogluconate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00138	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00137	CcSEcCtD
Sodium stibogluconate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Sodium stibogluconate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00135	CcSEcCtD
Sodium stibogluconate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00135	CcSEcCtD
Sodium stibogluconate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00135	CcSEcCtD
Sodium stibogluconate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Sodium stibogluconate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Sodium stibogluconate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Sodium stibogluconate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Sodium stibogluconate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.0013	CcSEcCtD
Sodium stibogluconate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00127	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00123	CcSEcCtD
Sodium stibogluconate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00123	CcSEcCtD
Sodium stibogluconate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00121	CcSEcCtD
Sodium stibogluconate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.0012	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00118	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00112	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.0011	CcSEcCtD
Sodium stibogluconate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000996	0.00103	CcSEcCtD
Sodium stibogluconate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000948	0.000978	CcSEcCtD
Sodium stibogluconate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000943	0.000973	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000929	0.000959	CcSEcCtD
Sodium stibogluconate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000916	0.000945	CcSEcCtD
Sodium stibogluconate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000897	0.000926	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000875	0.000903	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00089	CcSEcCtD
Sodium stibogluconate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000863	0.00089	CcSEcCtD
Sodium stibogluconate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000857	0.000885	CcSEcCtD
Sodium stibogluconate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000849	0.000876	CcSEcCtD
Sodium stibogluconate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000842	0.000869	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000834	0.000861	CcSEcCtD
Sodium stibogluconate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000822	0.000849	CcSEcCtD
Sodium stibogluconate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000785	0.00081	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000775	0.000799	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00075	0.000774	CcSEcCtD
Sodium stibogluconate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000749	0.000773	CcSEcCtD
Sodium stibogluconate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000748	0.000772	CcSEcCtD
Sodium stibogluconate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000744	0.000768	CcSEcCtD
Sodium stibogluconate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000744	0.000768	CcSEcCtD
Sodium stibogluconate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000738	0.000761	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000706	0.000728	CcSEcCtD
Sodium stibogluconate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000705	0.000728	CcSEcCtD
Sodium stibogluconate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000685	0.000707	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000682	0.000704	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000682	0.000704	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000636	0.000656	CcSEcCtD
Sodium stibogluconate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000619	0.000639	CcSEcCtD
Sodium stibogluconate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00061	0.00063	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00059	0.000609	CcSEcCtD
Sodium stibogluconate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000589	CcSEcCtD
Sodium stibogluconate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000549	0.000566	CcSEcCtD
Sodium stibogluconate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000544	0.000561	CcSEcCtD
Sodium stibogluconate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000544	0.000561	CcSEcCtD
Sodium stibogluconate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000541	0.000558	CcSEcCtD
Sodium stibogluconate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000513	0.000529	CcSEcCtD
